Login / Signup

Improved pulmonary function and exercise tolerance despite persistent pulmonary fibrosis over 1 year after severe COVID-19 infection.

Claire F McGroderMary M SalvatoreBelinda M D'SouzaEric A HoffmanMatthew R BaldwinChristine Kim Garcia
Published in: Thorax (2024)
We conducted a prospective single-centre cohort study of 104 multi-ethnic severe COVID-19 survivors from the first wave of the pandemic 15 months after hospitalisation. Of those who were assessed at 4 and 15 months, improvement of ground glass opacities correlated with worsened fibrotic reticulations. Despite a high prevalence of fibrotic patterns (64%), pulmonary function, grip strength, 6 min walk distance and frailty normalised. Overall, dyspnoea, cough and exhaustion did not improve and were not correlated with pulmonary function or radiographic fibrosis at 15 months, suggesting non-respiratory aetiologies. Monitoring persistent, and often subclinical, fibrotic interstitial abnormalities will be needed to determine their potential for future progression.
Keyphrases
  • coronavirus disease
  • sars cov
  • pulmonary fibrosis
  • systemic sclerosis
  • idiopathic pulmonary fibrosis
  • early onset
  • high intensity
  • young adults
  • physical activity
  • current status
  • drug induced
  • climate change
  • human health